tiprankstipranks
Trending News
More News >
DIH Holdings US, Inc Class A (DHAI)
OTHER OTC:DHAI
US Market

DIH Holdings US, Inc Class A (DHAI) AI Stock Analysis

Compare
69 Followers

Top Page

DHAI

DIH Holdings US, Inc Class A

(OTC:DHAI)

Select Model
Select Model
Select Model
Underperform 37 (OpenAI - 4o)
Rating:37Underperform
Price Target:
$0.03
▼(-6.67% Downside)
DIH Holdings US, Inc. is facing severe financial and operational challenges, including a negative financial performance, lack of technical data, poor valuation metrics, and significant negative corporate events such as delisting and leadership changes. These factors collectively result in a very low overall stock score, indicating high risk and uncertainty for investors.
Positive Factors
Strategic Partnerships
Strategic alliances with industry leaders enhance market reach and product offerings, providing a durable competitive advantage.
Product Diversification
Diversified product portfolio across technology and healthcare sectors mitigates risks and supports long-term growth potential.
Cash Flow Management
Positive free cash flow to net income ratio indicates effective cash management, supporting operational sustainability.
Negative Factors
Leadership Instability
Leadership changes can disrupt strategic direction and operational stability, impacting long-term business performance.
Nasdaq Delisting
Delisting from Nasdaq limits access to capital markets and reduces stock liquidity, affecting financial flexibility and investor confidence.
Negative Profitability Margins
Negative profitability margins reflect operational challenges and financial instability, hindering long-term growth and sustainability.

DIH Holdings US, Inc Class A (DHAI) vs. SPDR S&P 500 ETF (SPY)

DIH Holdings US, Inc Class A Business Overview & Revenue Model

Company DescriptionDIH Holding US, Inc. operates as a robotics and virtual reality technology provider in the rehabilitation and human performance industry. The company is based in Norwell, Massachusetts.
How the Company Makes MoneyDIH Holdings generates revenue through multiple streams, including the sale of its proprietary healthcare technology products, subscription fees from its software services, and partnerships with healthcare providers and institutions. The company leverages strategic alliances with industry leaders to expand its market reach and enhance its product offerings. Additionally, it may also earn revenue through consulting services related to technology integration and operational optimization within healthcare settings.

DIH Holdings US, Inc Class A Financial Statement Overview

Summary
DIH Holdings US, Inc Class A faces significant financial challenges with declining revenues, negative profitability margins, and a weak balance sheet characterized by negative equity. Cash flow issues further exacerbate the situation, although there is some ability to cover net losses with free cash flow.
Income Statement
The company has experienced a decline in revenue growth rate, with a negative growth of -5.89% in the latest year. Gross profit margin remains relatively stable at 51.24%, but net profit margin is negative, indicating ongoing losses. EBIT and EBITDA margins are also negative, reflecting operational challenges.
Balance Sheet
The balance sheet shows a negative stockholders' equity, leading to a negative debt-to-equity ratio. Return on equity is positive but reflects the negative equity base. The equity ratio is negative, indicating financial instability and potential risk.
Cash Flow
Cash flow analysis reveals a significant decline in free cash flow growth rate, down by -343.37%. Operating cash flow to net income ratio is negative, indicating cash flow issues. However, free cash flow to net income ratio is positive, suggesting some ability to cover net losses with free cash flow.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue62.86M62.86M64.47M55.00M49.04M47.52M
Gross Profit32.03M32.21M29.77M34.54M24.77M28.23M
EBITDA-7.11M-7.11M-6.20M652.00K-7.88M-9.63M
Net Income-8.68M-8.68M-8.44M-2.36M-12.05M-10.85M
Balance Sheet
Total Assets26.75M26.75M35.73M35.73M34.02M38.78M
Cash, Cash Equivalents and Short-Term Investments1.94M1.94M3.23M3.23M3.31M3.16M
Total Debt11.96M11.96M15.95M15.95M23.63M17.09M
Total Liabilities63.89M63.89M68.28M68.28M60.44M54.96M
Stockholders Equity-37.13M-37.13M-32.55M-32.55M-26.42M-16.18M
Cash Flow
Free Cash Flow-4.68M-4.68M4.99M6.02M-1.71M-5.74M
Operating Cash Flow-4.14M-4.14M5.19M6.18M-744.00K-4.99M
Investing Cash Flow-536.00K-536.00K-202.00K-163.00K-969.00K-1.12M
Financing Cash Flow3.39M3.39M-4.95M-3.66M2.04M2.16M

DIH Holdings US, Inc Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
$11.11M-0.36-197.26%-2.47%91.23%
46
Neutral
$10.65M-0.49-220.42%-41.03%35.71%
45
Neutral
$7.21M-0.4220.03%-99.28%-46.16%
43
Neutral
$7.89M-0.51-207.19%-5.19%-0.81%
38
Underperform
$8.49M-1.88-69.61%-11.31%47.64%
37
Underperform
$6.70K>-0.01
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DHAI
DIH Holdings US, Inc Class A
0.03
-34.22
-99.91%
SSKN
Strata Skin Sciences
1.34
-1.61
-54.58%
BMRA
Biomerica
2.88
0.31
12.06%
PAVM
PAVmed
7.29
-10.71
-59.50%
TNON
Tenon Medical, Inc.
1.00
-0.73
-42.20%
HSCS
Heart Test Laboratories, Inc.
3.35
0.13
4.04%

DIH Holdings US, Inc Class A Corporate Events

Executive/Board Changes
DIH Holdings CEO and Director Jason Chen Fully Departs
Negative
Dec 18, 2025

DIH Holding US, Inc. reported a leadership change involving its former chief executive. On November 24, 2025, Jason Chen informed the board that he was resigning as CEO of DIH Holding US, Inc.; on November 25, 2025, he extended his resignation to all equivalent roles at the company’s subsidiaries; and on December 15, 2025, he further resigned as a member of the board and from all board committees, with his resignation to be effective upon notice, marking a complete departure from all positions within the organization.

The most recent analyst rating on (DHAI) stock is a Sell with a $0.03 price target. To see the full list of analyst forecasts on DIH Holdings US, Inc Class A stock, see the DHAI Stock Forecast page.

Business Operations and StrategyDelistings and Listing Changes
DIH Holdings Faces Nasdaq Delisting and Trading Suspension
Negative
Nov 6, 2025

On November 5, 2025, DIH Holding US, Inc. received a determination letter from Nasdaq indicating that the company’s request to continue its listing was denied, leading to the delisting of its shares and suspension of trading on November 7, 2025. The company does not intend to request a review of this decision, and as a result, its shares will be traded over-the-counter, which may adversely affect their trading price and liquidity. Additionally, the company has decided to suspend its operations due to the delisting and the inability to secure additional capital, while it evaluates strategic alternatives.

The most recent analyst rating on (DHAI) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on DIH Holdings US, Inc Class A stock, see the DHAI Stock Forecast page.

Private Placements and FinancingRegulatory Filings and Compliance
DIH Holdings US Enters $22M Stock Purchase Agreement
Neutral
Oct 21, 2025

On October 15, 2025, DIH Holdings US, Inc. entered into a purchase agreement with an investor to sell up to $22 million in Class A common stock or 10,458,031 shares, representing 19.99% of the company’s voting power. The company plans to use the proceeds for working capital and general purposes, with the agreement allowing the investor to purchase shares at a discounted price. The issuance is exempt from registration under the Securities Act, with a registration statement to be filed for resale. The agreement will terminate automatically after 36 months unless terminated earlier.

Shareholder MeetingsStock Split
DIH Holdings US Implements Reverse Stock Split
Neutral
Oct 17, 2025

On October 17, 2025, DIH Holding US, Inc. implemented a one-for-twenty-five reverse stock split of its Class A common stock, following approval from its stockholders on September 25, 2025. The reverse stock split, effective at market open on October 20, 2025, aims to consolidate shares without affecting the total authorized shares or the par value, with stockholders receiving whole shares in place of fractional ones. This move is expected to streamline the company’s stock structure while maintaining stockholder ownership percentages and voting power.

Delistings and Listing ChangesRegulatory Filings and Compliance
DIH Holdings Faces Nasdaq Delisting Threat
Negative
Oct 8, 2025

DIH Holdings US, Inc. is facing potential delisting from the Nasdaq Stock Market due to non-compliance with several listing rules. The company has failed to meet the minimum market value of publicly held shares, market value of listed securities, and bid price requirements, as well as filing deadlines for financial reports. Despite requesting a hearing and an extension to address these deficiencies, there is no assurance that the Nasdaq Hearings Panel will grant the company’s request for continued listing or that it will achieve compliance within the allowed timeframe.

Delistings and Listing ChangesRegulatory Filings and Compliance
DIH Holdings Faces Delisting Risk Amid Nasdaq Notice
Negative
Oct 2, 2025

On March 11, 2025, DIH Holding US, Inc. received a notice from Nasdaq that its Class A common stock had closed below $1.00 for 30 consecutive business days, risking delisting under Nasdaq’s Bid Price Rule. By September 12, 2025, the company had not regained compliance and faced additional delisting risks due to delays in filing required financial reports. DIH requested a hearing to present a compliance plan and sought an extension to meet Nasdaq’s listing criteria, but there is no assurance of a favorable outcome.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025